Fernando Noriega

Title: Innovations by Fernando Noriega in Vaccine Development

Introduction

Fernando Noriega is an accomplished inventor based in Cresco, PA (US). He has made significant contributions to the field of vaccine development, particularly in relation to dengue virus diseases. With a total of 3 patents to his name, Noriega's work is pivotal in advancing public health.

Latest Patents

Noriega's latest patents include innovative compositions for booster vaccination against dengue. The first patent focuses on a method of booster vaccination and a vaccine composition designed to induce a neutralizing antibody response in individuals who have previously received primary vaccinations against all four serotypes of the dengue virus. This composition includes a dengue antigen from at least one of the serotypes or a nucleic acid construct capable of expressing these antigens. The booster vaccination aims to achieve a two-fold increase in the neutralizing antibody titre against each serotype. Another patent relates to vaccine compositions that protect human subjects against dengue disease, further showcasing his commitment to combating this viral infection.

Career Highlights

Noriega is currently associated with Sanofi Pasteur Inc., a leading company in vaccine development. His work at Sanofi Pasteur has allowed him to focus on creating effective solutions for dengue virus diseases, contributing to the company's mission of improving global health.

Collaborations

Throughout his career, Noriega has collaborated with notable colleagues, including Betzana Zambrano and Yves Girerd-Chambaz. These collaborations have enhanced the research and development of innovative vaccine solutions.

Conclusion

Fernando Noriega's contributions to vaccine development, particularly in the area of dengue virus, highlight his role as a key inventor in the field. His patents and work at Sanofi Pasteur Inc. reflect his dedication to improving public health through innovative solutions.